Tumour necrosis factor blockade in rheumatoid arthritis

By Breedveld Ferdinand C  

Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. : 107-109

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha  

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Tumour necrosis factor- blockade: a new era for effective management of rheumatoid arthritis

By Hamilton K.   St. Clair E.W.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1041-1052

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1502-1511

Bentham Science Publishers

Access to resources Recommend Favorite

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

By Fu Bo   Lunt Mark   Galloway James   Dixon Will   Hyrich Kimme   Symmons Deborah  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 461-476

Taylor & Francis Ltd

Access to resources Recommend Favorite